Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review

Detalhes bibliográficos
Autor(a) principal: Martines, Liz Joana Oliveira
Data de Publicação: 2021
Outros Autores: Silva Neto , Pedro Vieira da, Ortiz, Jessica Vanina
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/22952
Resumo: Introduction: Diabetes Mellitus (DM) is a public health issue as it represents the 3rd largest cause of death in the world, it causes several complications for the lives of its patients, including the diabetic foot, which has a great impact on the quality of life of the patient, and it is noteworthy that the treatment has a high financial cost. Describe the effectiveness of ozone therapy and Heberprot-P® in the treatment of diabetic foot ulcers. Methodology:  The search for scientific articles was performed in electronic databases: Scientific Electronic Library Online (SCIELO), Latin American Literature on Health Sciences (LILACS), National Library of Medicine and the National Institute of Health (Pubmed). Results and Discussion: When uncontrolled, in the long term, DM can lead to several complications, such as the diabetic foot, which is characterized by lesions on the individual's feet caused by the peculiar triad of DM: neuropathy, peripheral vascular disease and infection. The proper treatment of Diabetic Foot depends on a thorough clinical evaluation and a multidisciplinary team, which will provide counseling, treatment and follow-up. Final Considerations: The treatment of diabetic foot with Heberprot-P® and ozone therapy has been shown to be highly effective and cheaper than conventional treatments. Both present speed in the wound healing process, and a reduction in the length of hospital stay, as well as a reduction in the need for limb amputation. Remember that ozone therapy should not be used as a single treatment, but always in combination with another type of treatment.
id UNIFEI_430ac3736ca52c0047c1b49c04553ac8
oai_identifier_str oai:ojs.pkp.sfu.ca:article/22952
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review Heberprot-p® y ozonoterapia en el tratamiento de las úlceras diabéticas del pie: una revisión bibliográficaHeberprot-p® e ozônioterapia no tratamento de úlceras de pé diabético: uma revisão bibliográficaDiabetes mellitusHeberprot-PDiabetic footTherapyUlcers.Diabetes mellitusHeberprot-PPie diabéticoTerapiaÚlceras.Diabetes mellitusHeberprot-PPé diabéticoTerapiaÚlceras.Introduction: Diabetes Mellitus (DM) is a public health issue as it represents the 3rd largest cause of death in the world, it causes several complications for the lives of its patients, including the diabetic foot, which has a great impact on the quality of life of the patient, and it is noteworthy that the treatment has a high financial cost. Describe the effectiveness of ozone therapy and Heberprot-P® in the treatment of diabetic foot ulcers. Methodology:  The search for scientific articles was performed in electronic databases: Scientific Electronic Library Online (SCIELO), Latin American Literature on Health Sciences (LILACS), National Library of Medicine and the National Institute of Health (Pubmed). Results and Discussion: When uncontrolled, in the long term, DM can lead to several complications, such as the diabetic foot, which is characterized by lesions on the individual's feet caused by the peculiar triad of DM: neuropathy, peripheral vascular disease and infection. The proper treatment of Diabetic Foot depends on a thorough clinical evaluation and a multidisciplinary team, which will provide counseling, treatment and follow-up. Final Considerations: The treatment of diabetic foot with Heberprot-P® and ozone therapy has been shown to be highly effective and cheaper than conventional treatments. Both present speed in the wound healing process, and a reduction in the length of hospital stay, as well as a reduction in the need for limb amputation. Remember that ozone therapy should not be used as a single treatment, but always in combination with another type of treatment.Introducción: La Diabetes Mellitus (DM) es un problema de salud pública ya que representa la tercera causa de muerte en el mundo, ocasiona varias complicaciones para la vida de sus pacientes, entre ellos el pie diabético, el cual tiene un gran impacto en la calidad de vida de paciente, y es de destacar que el tratamiento tiene un alto costo económico. Por lo tanto, el objetivo deste trabajo fué describir la eficácia de la ozonoterapia y Heberprot-P® en el tratamiento de las úlceras del pie diabético. Metodología: La búsqueda de artículos científicos se realizó en bases de datos electrónicas: Scientific Electronic Library Online (SCIELO), Literatura Latinoamericana en Ciencias de la Salud (LILACS), Biblioteca Nacional de Medicina e Instituto Nacional de Salud (Pubmed). Resultados y discusión: Cuando no se controla, a largo plazo, la DM puede dar lugar a diversas complicaciones, como el pie diabético, que se caracteriza por lesiones en el pie del individuo provocadas por la peculiar tríada de la DM: neuropatía, vasculopatía periférica e infección. El tratamiento adecuado del pie diabético depende de una evaluación clínica exhaustiva y de un equipo multidisciplinario, que brindará asesoramiento, tratamiento y seguimiento. Consideraciones finales: El tratamiento del pie diabético con Heberprot-P® y la ozonoterapia ha demostrado ser muy eficaz y más económico que los tratamientos convencionales. Ambos presentan rapidez en el proceso de cicatrización de heridas, reducción de la estancia hospitalaria y reducción de la necesidad de amputación de miembros. Recuerda que la ozonoterapia no debe utilizarse como tratamiento único, sino siempre en combinación con otro tipo de tratamiento.Introdução: O Diabetes Mellitus (DM) é uma questão de saúde pública por representar, a 3ª maior causa de mortes no mundo, ela acarreta diversas complicações para a vida de seus portadores, dentre elas o pé diabético que tem um grande impacto sobre a qualidade de vida do paciente, e vale ressaltar que o tratamento tem um elevado custo financeiro. Portanto, o objetivo deste trabalho foi descrever a eficácia da ozônioterapia e do Heberprot-P® no tratamento de úlceras de pé diabético. Metodologia: O estudo é uma revisão bibliográfica em que a busca de artigos científicos foi realizada nas bases de dados eletrônicas: Scientific Electronic Library Online (SCIELO), Literatura Latino-Americana em Ciências da Saúde (LILACS) e National Library of Medicine and the National Institute of Health (Pubmed). Resultados e discussão: Quando não controlada, em longo prazo, a DM pode acarretar diversas complicações, como o pé diabético que é caracterizado por lesões nos pés do indivíduo ocasionado pela tríade peculiar do DM: neuropatia, doença vascular periférica e infecção. O tratamento do pé diabético adequado depende da avaliação clínica minuciosa e da equipe multidisciplinar, que irá fazer o aconselhamento, tratamento e acompanhamento. Considerações finais: O tratamento do pé diabético com o Heberprot-P® e ozônioterapia tem se demonstrado de grande eficácia e de custo financeiro mais baixo que os tratamentos convencionais.  Ambos apresentam celeridade no processo de cicatrização da ferida, e diminuição no tempo de internação, bem como redução na necessidade de amputação de membros. Vale lembrar que a ozônioterapia não deve ser utilizada como tratamento único, mas sim, sempre em combinação a outro tipo de tratamento.Research, Society and Development2021-11-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2295210.33448/rsd-v10i15.22952Research, Society and Development; Vol. 10 No. 15; e402101522952Research, Society and Development; Vol. 10 Núm. 15; e402101522952Research, Society and Development; v. 10 n. 15; e4021015229522525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/22952/20230Copyright (c) 2021 Liz Joana Oliveira Martines; Pedro Vieira da Silva Neto ; Jessica Vanina Ortizhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMartines, Liz Joana OliveiraSilva Neto , Pedro Vieira da Ortiz, Jessica Vanina2021-12-06T10:13:53Zoai:ojs.pkp.sfu.ca:article/22952Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:58.024805Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
Heberprot-p® y ozonoterapia en el tratamiento de las úlceras diabéticas del pie: una revisión bibliográfica
Heberprot-p® e ozônioterapia no tratamento de úlceras de pé diabético: uma revisão bibliográfica
title Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
spellingShingle Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
Martines, Liz Joana Oliveira
Diabetes mellitus
Heberprot-P
Diabetic foot
Therapy
Ulcers.
Diabetes mellitus
Heberprot-P
Pie diabético
Terapia
Úlceras.
Diabetes mellitus
Heberprot-P
Pé diabético
Terapia
Úlceras.
title_short Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
title_full Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
title_fullStr Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
title_full_unstemmed Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
title_sort Heberprot-p® and ozone therapy in the treatment of diabetic foot ulcers: a bibliographic review
author Martines, Liz Joana Oliveira
author_facet Martines, Liz Joana Oliveira
Silva Neto , Pedro Vieira da
Ortiz, Jessica Vanina
author_role author
author2 Silva Neto , Pedro Vieira da
Ortiz, Jessica Vanina
author2_role author
author
dc.contributor.author.fl_str_mv Martines, Liz Joana Oliveira
Silva Neto , Pedro Vieira da
Ortiz, Jessica Vanina
dc.subject.por.fl_str_mv Diabetes mellitus
Heberprot-P
Diabetic foot
Therapy
Ulcers.
Diabetes mellitus
Heberprot-P
Pie diabético
Terapia
Úlceras.
Diabetes mellitus
Heberprot-P
Pé diabético
Terapia
Úlceras.
topic Diabetes mellitus
Heberprot-P
Diabetic foot
Therapy
Ulcers.
Diabetes mellitus
Heberprot-P
Pie diabético
Terapia
Úlceras.
Diabetes mellitus
Heberprot-P
Pé diabético
Terapia
Úlceras.
description Introduction: Diabetes Mellitus (DM) is a public health issue as it represents the 3rd largest cause of death in the world, it causes several complications for the lives of its patients, including the diabetic foot, which has a great impact on the quality of life of the patient, and it is noteworthy that the treatment has a high financial cost. Describe the effectiveness of ozone therapy and Heberprot-P® in the treatment of diabetic foot ulcers. Methodology:  The search for scientific articles was performed in electronic databases: Scientific Electronic Library Online (SCIELO), Latin American Literature on Health Sciences (LILACS), National Library of Medicine and the National Institute of Health (Pubmed). Results and Discussion: When uncontrolled, in the long term, DM can lead to several complications, such as the diabetic foot, which is characterized by lesions on the individual's feet caused by the peculiar triad of DM: neuropathy, peripheral vascular disease and infection. The proper treatment of Diabetic Foot depends on a thorough clinical evaluation and a multidisciplinary team, which will provide counseling, treatment and follow-up. Final Considerations: The treatment of diabetic foot with Heberprot-P® and ozone therapy has been shown to be highly effective and cheaper than conventional treatments. Both present speed in the wound healing process, and a reduction in the length of hospital stay, as well as a reduction in the need for limb amputation. Remember that ozone therapy should not be used as a single treatment, but always in combination with another type of treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-24
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/22952
10.33448/rsd-v10i15.22952
url https://rsdjournal.org/index.php/rsd/article/view/22952
identifier_str_mv 10.33448/rsd-v10i15.22952
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/22952/20230
dc.rights.driver.fl_str_mv Copyright (c) 2021 Liz Joana Oliveira Martines; Pedro Vieira da Silva Neto ; Jessica Vanina Ortiz
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Liz Joana Oliveira Martines; Pedro Vieira da Silva Neto ; Jessica Vanina Ortiz
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 15; e402101522952
Research, Society and Development; Vol. 10 Núm. 15; e402101522952
Research, Society and Development; v. 10 n. 15; e402101522952
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052696452136960